Edition:
United Kingdom

DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

129.00USD
19 Oct 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$129.00
Open
$136.00
Day's High
$136.57
Day's Low
$128.71
Volume
402,812
Avg. Vol
343,054
52-wk High
$148.50
52-wk Low
$43.77

Latest Key Developments (Source: Significant Developments)

Agamatrix Says Judge Issued Order To Dexcom To Pay Co Its Costs Defending Against Case Since August 1, 2017
Tuesday, 5 Jun 2018 

June 5 (Reuters) - DexCom Inc ::AGAMATRIX - PREVAILING OUTCOME IN RETALIATORY PATENT INFRINGEMENT LAWSUIT BROUGHT BY DEXCOM INC.AGAMATRIX - JUDGE ISSUED ORDER IN MAY ORDERING DEXCOM TO PAY AGAMATRIX ITS COSTS, ATTORNEYS' FEES, EXPENSES DEFENDING AGAINST CASE SINCE AUGUST 1, 2017.AGAMATRIX - FEES CO IS REQUESTING ARE ABOUT $1.4 MILLION.  Full Article

DexCom Says Preliminary Q4 Revenue Was $218 Mln
Monday, 8 Jan 2018 

Jan 8 (Reuters) - DexCom Inc ::DEXCOM REPORTS RECORD PRELIMINARY, UNAUDITED REVENUE FOR THE FOURTH QUARTER AND FISCAL YEAR 2017 AND PROVIDES INITIAL 2018 OUTLOOK.SEES FY 2018 REVENUE ABOUT $830 MILLION TO $850 MILLION.SEES FY 2017 REVENUE ABOUT $715 MILLION.PRELIMINARY Q4 REVENUE $218 MILLION VERSUS I/B/E/S VIEW $212.6 MILLION .FY2017 REVENUE VIEW $710.2 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $854.6 MILLION -- THOMSON REUTERS I/B/E/S.Q4 REVENUE VIEW $212.7 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Dexcom announces development agreement with Lilly
Tuesday, 21 Nov 2017 

Nov 21 (Reuters) - Dexcom Inc ::Dexcom announces development agreement with Lilly to integrate Dexcom CGM into connected diabetes ecosystem.Says ‍companies expect to combine Lilly's smart insulin delivery devices and Dexcom CGM.  Full Article

Dexcom Inc reports Q3 GAAP loss per share $0.02
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Dexcom Inc :Dexcom, inc. Reports record third quarter 2017 financial results.Q3 non-gaap loss per share $0.04.Q3 gaap loss per share $0.02.Q3 revenue $184.6 million versus i/b/e/s view $184.2 million.Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S.  Full Article

‍Tandem Diabetes Care to provide all t:slim X2 insulin pump features approved in 2018 to users at no cost
Tuesday, 24 Oct 2017 

Oct 24 (Reuters) - Tandem Diabetes Care Inc ::‍Tandem Diabetes Care to provide all t:slim x2 insulin pump features approved in 2018 to users at no cost, expands existing dexcom welcome offer for animas customers​.Tandem diabetes care inc - ‍tandem and Dexcom are now extending terms of their welcome programs for animas customers through march 31, 2018​.  Full Article

‍Janus Henderson reports 10.2 pct passive stake in Dexcom
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - ‍Janus Henderson Group PLC:‍Janus Henderson Group PLC reports a 10.2 percent passive stake in Dexcom Inc as of sept 30 - SEC filing​.  Full Article

  • Previous
  • Next

DexCom Inc News

BRIEF-Novo Nordisk Plans First Global Launch Of Connected Insulin Pens

* NOVO NORDISK PLANS FIRST GLOBALLAUNCH OF CONNECTED INSULIN PENS AND ANNOUNCES KEY DIGITAL HEALTH PARTNERSHIPS

» More DXCM.OQ News

Earnings vs. Estimates

» More Financials